|
|
|
Publications
|
|
WinPOPT:
- McGree JM, Duffull SB, Eccleston JA, Ward LC. Optimal
designs for studying bioimpedance Physiol Meas 2007; 28:
1465–1483
- Denman N, Mould D, Duffull S. Study Designs to Assess the Placebo Response (PBO-R) for Hamilton
Depression (HAMD) Scores for Depression. AAPS Poster 2006.
- Mould D, Denman N, Duffull S. Using disease progression models as
a tool to detect drug effect Clin Pharmacol Ther 2007;
82:81-86
POPT:
- Hennig, S., Waterhouse, T.H.,
Bell, S.C., France,
M., Wainwright, C.E., Miller, H., Charles, B.G. and Duffull, S.B. A D-optimal designed population
pharmacokinetic study of oral itraconazole in adult cystic fibrosis
patients. BJCP (accepted
2006)
- Duffull,
S.B., Waterhouse, T.H. and Eccleston, J.A. Some considerations on
the design of population pharmacokinetic studies.J. Pharmacokinetic Pharmacodyn. 2005; 32:441-457
- Waterhouse,
T.H., Redmann, S., Duffull, S.B. and
Eccleston, J.A. Optimal design for model discrimination and
parameter estimation for itraconazole population pharmacokinetics in
cystic fibrosis patients.J. Pharmacokinetic Pharmacodyn.
2005; 32:521-545
- Green,
B. and Duffull, S.B. Prospective evaluation of a D-optimal designed
population pharmacokinetic study. J. Pharmacokinetic Pharmacodyn. 2003; 30:145-161
- Duffull,
S.B., Retout, S. and Mentré, F. The use of simulated annealing for finding optimal
population designs. Comp. Methods Programs Biomed. 2002; 69:25-35.
- Duffull, S.B., Mentré, F. and Aarons, L. Optimal design of a population
pharmacodynamic experiment for ivabradine.
Pharm. Res. 2001; 18:83-89.
|
|
|
Copyright WinPOPT 2006
|
|